Gabelli Funds LLC Raises Stock Holdings in Align Technology, Inc. $ALGN

Posted by George Bondi on May 23rd, 2026

Gabelli Funds LLC boosted its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 62.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 10,400 shares of the medical equipment provider’s stock after purchasing an additional 4,000 shares during the period. Gabelli Funds LLC’s holdings in Align Technology were worth $1,624,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Comerica Bank lifted its stake in Align Technology by 0.6% in the fourth quarter. Comerica Bank now owns 13,656 shares of the medical equipment provider’s stock worth $2,132,000 after acquiring an additional 76 shares during the period. Arizona State Retirement System raised its holdings in Align Technology by 0.4% in the third quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock worth $2,553,000 after purchasing an additional 79 shares in the last quarter. Sentry Investment Management LLC increased its holdings in shares of Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 79 shares in the last quarter. Independence Bank of Kentucky increased its holdings in shares of Align Technology by 77.7% during the fourth quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares in the last quarter. Finally, Allworth Financial LP increased its holdings in shares of Align Technology by 3.3% during the third quarter. Allworth Financial LP now owns 2,874 shares of the medical equipment provider’s stock valued at $360,000 after acquiring an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

NASDAQ ALGN opened at $163.61 on Friday. The business’s 50 day moving average price is $173.96 and its 200-day moving average price is $167.18. The company has a market cap of $11.72 billion, a P/E ratio of 27.45, a P/E/G ratio of 1.67 and a beta of 1.70. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $208.30.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share for the quarter, topping the consensus estimate of $2.26 by $0.32. The business had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.13 EPS. As a group, equities analysts predict that Align Technology, Inc. will post 9.48 EPS for the current year.

Align Technology declared that its Board of Directors has authorized a share repurchase plan on Wednesday, April 29th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to repurchase up to 1.6% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Jefferies Financial Group raised their price target on Align Technology from $155.00 to $185.00 and gave the company a “hold” rating in a report on Thursday, February 5th. Citigroup started coverage on Align Technology in a report on Wednesday, April 15th. They issued a “buy” rating and a $240.00 price objective for the company. Mizuho raised their target price on Align Technology from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Robert W. Baird set a $218.00 target price on Align Technology in a research report on Thursday, February 5th. Finally, Morgan Stanley raised their target price on Align Technology from $169.00 to $188.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $205.85.

Check Out Our Latest Analysis on ALGN

Align Technology Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Gabelli Funds LLC Raises Stock Holdings in Align Technology, Inc. $ALGN

Align Technology Stock Performance

Analyst Upgrades and Downgrades

Align Technology Profile

See Also

You might be interested in: